Moser, C., Lang, S. A., Mori, A., Hellerbrand, C., Schlitt, H. J., Geissler, E. K., . . . Stoeltzing, O. (2008). ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo. BioMed Central.

Moser, Christian, Sven A. Lang, Akira Mori, Claus Hellerbrand, Hans J. Schlitt, Edward K. Geissler, William E. Fogler, ja Oliver Stoeltzing. ENMD-1198, a Novel Tubulin-binding Agent Reduces HIF-1alpha and STAT3 Activity in Human Hepatocellular Carcinoma(HCC) Cells, and Inhibits Growth and Vascularization in Vivo. BioMed Central, 2008.

Moser, Christian, et al. ENMD-1198, a Novel Tubulin-binding Agent Reduces HIF-1alpha and STAT3 Activity in Human Hepatocellular Carcinoma(HCC) Cells, and Inhibits Growth and Vascularization in Vivo. BioMed Central, 2008.